Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| MSN Pharmaceuticals Inc | Piscataway, NJ, United States | Makes it and tests it | No problems foundMar 13, 2026 · 3 inspections |
Recalls
- Dec 15, 2025 · Class III · Novadoz Pharmaceuticals Llc
Failed Impurities/Degradation Specifications
Lots: Lot # CB2505159A, CB2505160A, Exp Date: 04/2027; Lot # CB2505161A, Exp Date: 05/2027
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Glycopyrronium: every company that makes it
- Form
- liquid, oral
- Strength
- 1 mg per 5 mL
- Approval
- ANDA ANDA216084
- On the market since
- Apr 8, 2025
- Package NDCs
72205-070-72- Official label
- DailyMed (National Library of Medicine), updated Jun 14, 2022
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?